FDA NDC Directory · JSON-LD · Markdown

Ultomiris

NDC 25682-028 · HUMAN PRESCRIPTION DRUG · SOLUTION, CONCENTRATE

Generic nameravulizumab
Labeler / ManufacturerAlexion Pharmaceuticals Inc.
Marketing categoryBiologic License Application · App BLA761108
Dosage form / routeSOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsRAVULIZUMAB (1100 mg/11mL)
Marketing started20201009
Package count1

External sources

Source: openFDA. Public-domain (CC0).